WHO Chief acknowledges India’s power over corona vaccine, country moves one step towards COVISHIELD

World Health Organization Director-General Tedrose Adenholm Gebrehes has praised India’s efforts in dealing with coronaviruses. He also thanked Prime Minister Narendra Modi for his commitment to providing effective vaccines against Corona to the world. In a tweet made in Hindi from his Twitter account, Tedrose said, “Namaste, Prime Minister Narendra Modi, you spoke to strengthen
 | 
WHO Chief acknowledges India’s power over corona vaccine, country moves one step towards COVISHIELD

World Health Organization Director-General Tedrose Adenholm Gebrehes has praised India’s efforts in dealing with coronaviruses. He also thanked Prime Minister Narendra Modi for his commitment to providing effective vaccines against Corona to the world.

In a tweet made in Hindi from his Twitter account, Tedrose said, “Namaste, Prime Minister Narendra Modi, you spoke to strengthen and strengthen cooperation for knowledge, research and training in the context of traditional medicine. WHO welcomes India’s leadership in health globally and in universal health coverage! ”

In the next tweet, the WHO chief said, “Thank you Prime Minister Modi for your strong commitment to COVAX and emphasis on making the COVID-19 vaccine available globally.” Pandemic is a huge challenge for the world, and we will work shoulder to shoulder to end it. ”

Let me tell you that on Wednesday evening, PM Modi told me that he talked to WHO Chief Tedrose. The PM had said that he had discussed the capabilities of traditional medicines for health and well-being worldwide. The PM had said that he also spoke of helping the World Health Organization and the whole world against Corona.

Clinical Testing of American Vaccines in India Now: Meanwhile, Serum Institute of India and ICMR have completed recruitment of Volunteers for the third phase trial of Vaccine Covishield of Oxford University and Astra Janeca in India. In addition, the Serum Institute will now work with ICMR on the clinical development of the US company Novavax’s Corona vaccine COVOVAX.